Currently, there is evidence supporting the use of either an angiotensin receptor blocker or an angiotensin-converting enzyme inhibitor in the primary-prevention context. However, in the secondary ...

Currently, AT-II-receptor antagonists are used either as monotherapy in patients who cannot tolerate ACE inhibitors or in combination with other antihypertensive agents. Angiotensin II-receptor ...

Before receiving a kidney transplant, patients with autosomal dominant polycystic kidney disease often undergo a nephrectomy. But there hasn’t been clear guidance on who’s a good candidate ...

High blood pressure, or hypertension, affects more than 1 billion people globally. Many of them are prescribed angiotensin-converting enzyme inhibitors—better known as ACE-1 inhibitors (ACEIs)—and/or ...

Lorundrostat, a selective aldosterone synthase inhibitor, significantly reduced systolic blood pressure in patients with ...

Cardiovascular diseases are the world's leading cause of death, and high blood pressure, or hypertension, affects more than 1 ...

Researchers in a new Chinese study discovered that “intensive blood pressure control" resulted in a 15% reduced dementia risk ...

ACE inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19 Mar 23, 2020 Study finds high blood pressure medications safe for patients with COVID-19 disease ...

Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

The Heart Failure Drugs Market is poised for a transformative decade between 2025 and 2035. As heart failure continues to pose a major global health challenge, the demand for effective therapeutic ...

Many of them are prescribed angiotensin-converting enzyme inhibitors—better known as ACE-1 inhibitors (ACEIs)—and/or angiotensin receptor blockers ... would like to use his plant-encapsulation ...